Cargando…

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

INTRODUCTION: While polysubstance use has consistently been associated with higher rates of relapse, few studies have examined subgroups with specific combinations and time course of polysubstance use (i.e., polysubstance use patterns). This study aimed to classify and compare polysubstance use patt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yue, Feaster, Daniel J., Odom, Gabriel, Brandt, Laura, Hu, Mei-Chen, Weiss, Roger D., Rotrosen, John, Saxon, Andrew J., Luo, Sean X., Balise, Raymond R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838120/ https://www.ncbi.nlm.nih.gov/pubmed/36644227 http://dx.doi.org/10.1016/j.dadr.2022.100128

Ejemplares similares

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values
por: Odom, Gabriel J., et al.
Publicado: (2023)

Polysubstance use in the U.S. opioid crisis
por: Compton, Wilson M., et al.
Publicado: (2020)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
por: Keyes, Katherine M., et al.
Publicado: (2022)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Longitudinal cognitive development of children born to mothers with opioid and polysubstance use
por: Nygaard, Egil, et al.
Publicado: (2015)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
por: Guille, Constance, et al.
Publicado: (2022)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Substance-Specific and Shared Gray Matter Signatures in Alcohol, Opioid, and Polysubstance Use Disorder
por: Muller, Angela M., et al.
Publicado: (2022)

Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
por: Vallecillo, Gabriel, et al.
Publicado: (2022)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use
por: Winkelman, Tyler N.A., et al.
Publicado: (2018)

Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder
por: Ford, Becky R., et al.
Publicado: (2021)

Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis
por: Bogdanowicz, Karolina Magda, et al.
Publicado: (2016)

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
por: Anderson Goodell, Erin M., et al.
Publicado: (2021)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
por: Martin, Anna K., et al.
Publicado: (2023)

Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study
por: Allen, Alicia, et al.
Publicado: (2023)

Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
por: Shearer, Riley D., et al.
Publicado: (2023)

Validation and endorsement of health system performance measures for opioid use disorder in British Columbia, Canada: A Delphi panel study
por: Kamran, Hasham, et al.
Publicado: (2022)

Enteral enriched nutrition to prevent cognitive dysfunction after surgery; a study in rats
por: Hovens, Iris B., et al.
Publicado: (2021)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Neighborhoods and adolescent polysubstance use in Jamaica
por: Gill, Amrita, et al.
Publicado: (2023)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022)

One Is Not Enough: Understanding and Modeling Polysubstance Use
por: Crummy, Elizabeth A., et al.
Publicado: (2020)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada
por: Bouck, Zachary, et al.
Publicado: (2023)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aj7uudj6i1jvb85rq0udbcau4g